Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD)

被引:20
作者
Bentivegna, Steven [1 ]
Zheng, Jianbiao [2 ]
Namsaraevz, Eugeni [2 ]
Carlton, Victoria E. H. [2 ]
Pavlicek, Adam [3 ]
Moorhead, Martin [2 ]
Siddiqui, Farooq [2 ]
Wang, Zhiyong [2 ]
Lee, Liana [2 ]
Ireland, James S. [2 ]
Suyenaga, Kent [2 ]
Willis, Thomas D. [2 ]
Faham, Malek [2 ]
Seymour, Albert B. [4 ]
机构
[1] Pfizer Inc, Groton Labs, Mol Profiling Pharmacogenom, Groton, CT 06340 USA
[2] Affymetrix Inc, San Francisco, CA USA
[3] Pfizer Global Res & Dev, La Jolla Labs, Computat Biol, La Jolla, CA USA
[4] Pfizer Res Technol Ctr, Biol Profiling, Cambridge, MA USA
关键词
mismatch repair detection; somatic mutation screening; colon; breast;
D O I
10.1002/humu.20672
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mismatch repair detection (MRD) was used to screen 93 matched tumor-normal sample pairs and 22 cell lines for somatic mutations in 30 cancer relevant genes. Using a starting amount of only 150 ng of genomic DNA, we screened 102 kb of sequence for somatic mutations in colon and breast cancer. A total of 152 somatic mutations were discovered, encompassing previously reported mutations, such as BRAF V600E and KRAS G12S, G12V, and G13D, as well as novel mutations, including some in genes in which somatic mutations have not previously been reported, such as MAP2K1 and MAP2K2. The distribution of mutations ranged widely within and across tumor types. The functional significance of many of these mutations is not understood, with patterns of selection only evident in KRAS and BRAF in colon cancer. These results present a novel approach to high,throughput mutation screening using small amounts of starting material and reveal a mutation spectrum across 30 genes in a large cohort of breast and colorectal cancers.
引用
收藏
页码:441 / 450
页数:10
相关论文
共 31 条
[1]  
Al-Mulla F, 1999, J PATHOL, V187, P433, DOI 10.1002/(SICI)1096-9896(199903)187:4<433::AID-PATH273>3.0.CO
[2]  
2-E
[3]   Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study [J].
Andreyev, HJN ;
Norman, AR ;
Cunningham, D ;
Oates, J ;
Dix, BR ;
Iacopetta, BJ ;
Young, J ;
Walsh, T ;
Ward, R ;
Hawkins, N ;
Beranek, M ;
Jandik, P ;
Benamouzig, R ;
Jullian, E ;
Laurent-Puig, P ;
Olschwang, S ;
Muller, O ;
Hoffmann, I ;
Rabes, HM ;
Zietz, C ;
Troungos, C ;
Valavanis, C ;
Yuen, ST ;
Ho, JWC ;
Croke, CT ;
O'Donoghue, DP ;
Giaretti, W ;
Rapallo, A ;
Russo, A ;
Bazan, V ;
Tanaka, M ;
Omura, K ;
Azuma, T ;
Ohkusa, T ;
Fujimori, T ;
Ono, Y ;
Pauly, M ;
Faber, C ;
Glaesener, R ;
de Goeij, AFPM ;
Arends, JW ;
Andersen, SN ;
Lövig, T ;
Breivik, J ;
Gaudernack, G ;
Clausen, OPF ;
De Angelis, P ;
Meling, GI ;
Rognum, TO ;
Smith, R .
BRITISH JOURNAL OF CANCER, 2001, 85 (05) :692-696
[4]   A quantitative measurement of the human somatic mutation rate [J].
Araten, DJ ;
Golde, DW ;
Zhang, RH ;
Thaler, HT ;
Gargiulo, L ;
Notaro, R ;
Luzzatto, L .
CANCER RESEARCH, 2005, 65 (18) :8111-8117
[5]  
Boland CR, 1998, CANCER RES, V58, P5248
[6]   High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance [J].
Branford, S ;
Rudzki, Z ;
Walsh, S ;
Grigg, A ;
Arthur, C ;
Taylor, K ;
Herrmann, R ;
Lynch, KP ;
Hughes, TP .
BLOOD, 2002, 99 (09) :3472-3475
[7]   Differential nonsense mediated decay of mutated mRNAs in mismatch repair deficient colorectal cancers [J].
El-Bchiri, J ;
Buhard, O ;
Penard-Lacronique, V ;
Thomas, G ;
Hamelin, R ;
Duval, A .
HUMAN MOLECULAR GENETICS, 2005, 14 (16) :2435-2442
[8]   Multiplexed variation scanning for 1,000 amplicons in hundreds of patients using mismatch repair detection (MRD) on tag arrays [J].
Faham, M ;
Zheng, JB ;
Moorhead, M ;
Fakhrai-Rad, H ;
Namsaraev, E ;
Wong, K ;
Wang, ZY ;
Chow, SG ;
Lee, L ;
Suyenaga, K ;
Reichert, J ;
Boudreau, A ;
Eberle, J ;
Bruckner, C ;
Jain, M ;
Karlin-Neumann, G ;
Jones, HB ;
Willis, TD ;
Buxbaum, JD ;
Davis, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (41) :14717-14722
[9]   Mismatch repair detection (MRD): high-throughput scanning for DNA variations [J].
Faham, M ;
Baharloo, S ;
Tomitaka, S ;
DeYoung, J ;
Freimer, NB .
HUMAN MOLECULAR GENETICS, 2001, 10 (16) :1657-1664
[10]   ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background [J].
Fang, Y ;
Tsao, CC ;
Goodman, BK ;
Furumai, R ;
Tirado, CA ;
Abraham, RT ;
Wang, XF .
EMBO JOURNAL, 2004, 23 (15) :3164-3174